118 related articles for article (PubMed ID: 8062274)
21. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
22. p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes.
Marchetti A; Buttitta F; Merlo G; Diella F; Pellegrini S; Pepe S; Macchiarini P; Chella A; Angeletti CA; Callahan R
Cancer Res; 1993 Jun; 53(12):2846-51. PubMed ID: 8389245
[TBL] [Abstract][Full Text] [Related]
23. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
[TBL] [Abstract][Full Text] [Related]
24. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
Komuro H; Hayashi Y; Kawamura M; Hayashi K; Kaneko Y; Kamoshita S; Hanada R; Yamamoto K; Hongo T; Yamada M
Cancer Res; 1993 Nov; 53(21):5284-8. PubMed ID: 8221663
[TBL] [Abstract][Full Text] [Related]
25. Alterations of (CA)n DNA repeats and tumor suppressor genes in human gastric cancer.
Mironov NM; Aguelon MA; Potapova GI; Omori Y; Gorbunov OV; Klimenkov AA; Yamasaki H
Cancer Res; 1994 Jan; 54(1):41-4. PubMed ID: 8261459
[TBL] [Abstract][Full Text] [Related]
26. Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma.
Ott K; Vogelsang H; Mueller J; Becker K; Müller M; Fink U; Siewert JR; Höfler H; Keller G
Clin Cancer Res; 2003 Jun; 9(6):2307-15. PubMed ID: 12796400
[TBL] [Abstract][Full Text] [Related]
27. Diverse hypermutability of multiple expressed sequence motifs present in a cancer with microsatellite instability.
Eshleman JR; Markowitz SD; Donover PS; Lang EZ; Lutterbaugh JD; Li GM; Longley M; Modrich P; Veigl ML; Sedwick WD
Oncogene; 1996 Apr; 12(7):1425-32. PubMed ID: 8622858
[TBL] [Abstract][Full Text] [Related]
28. Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes.
Ren ZP; Hedrum A; Pontén F; Nistér M; Ahmadian A; Lundeberg J; Uhlén M; Pontén J
Oncogene; 1996 Feb; 12(4):765-73. PubMed ID: 8632898
[TBL] [Abstract][Full Text] [Related]
29. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
[TBL] [Abstract][Full Text] [Related]
30. Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect.
Agaimy A; Dirnhofer S; Wünsch PH; Terracciano LM; Tornillo L; Bihl MP
Am J Surg Pathol; 2008 Oct; 32(10):1553-9. PubMed ID: 18724245
[TBL] [Abstract][Full Text] [Related]
31. Multiple detection of genetic alterations in tumors and stool.
Rengucci C; Maiolo P; Saragoni L; Zoli W; Amadori D; Calistri D
Clin Cancer Res; 2001 Mar; 7(3):590-3. PubMed ID: 11297253
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
[TBL] [Abstract][Full Text] [Related]
33. p53 Mutations and microsatellite instability in ovarian cancer: Yin and yang.
Buller RE; Shahin MS; Holmes RW; Hatterman M; Kirby PA; Sood AK
Am J Obstet Gynecol; 2001 Apr; 184(5):891-902; discussion 902-3. PubMed ID: 11303196
[TBL] [Abstract][Full Text] [Related]
34. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
35. Sites and types of p53 mutations in an unselected series of colorectal cancers in The Netherlands.
Van Den Broek MH; Renault B; Fodde R; Verspaget H; Griffioen G; Khan PM
Anticancer Res; 1993; 13(3):587-92. PubMed ID: 8317886
[TBL] [Abstract][Full Text] [Related]
36. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
37. Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype.
Ohmura K; Tamura G; Endoh Y; Sakata K; Takahashi T; Motoyama T
Hum Pathol; 2000 Sep; 31(9):1031-5. PubMed ID: 11014567
[TBL] [Abstract][Full Text] [Related]
38. Analysis of p53 abnormalities in endoscopic gastric biopsies.
Imatani A; Sasano H; Asaki S; Toyota T; Saito M; Masuda T; Nagura H
Anticancer Res; 1996; 16(4A):2049-56. PubMed ID: 8712741
[TBL] [Abstract][Full Text] [Related]
39. Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations.
Shahedian B; Shi Y; Zou M; Farid NR
Mol Genet Metab; 2001 Feb; 72(2):155-63. PubMed ID: 11161841
[TBL] [Abstract][Full Text] [Related]
40. Frequent p53 gene mutations and novel alleles in familial breast cancer.
Glebov OK; McKenzie KE; White CA; Sukumar S
Cancer Res; 1994 Jul; 54(14):3703-9. PubMed ID: 8033087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
